The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects
Cannon, Megan V., Yu, Hongjuan, Candido, Wellington M., Dokter, Martin M., Lindstedt, Eva-Lotte, Silljé, Herman H.W., van Gilst, Wiek H., de Boer, Rudolf A.Volume:
17
Language:
english
Journal:
European Journal of Heart Failure
DOI:
10.1002/ejhf.243
Date:
March, 2015
File:
PDF, 641 KB
english, 2015